Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)

SHE:301126 Revenue

Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd had revenue of 1.38B CNY in the quarter ending March 31, 2026, with 6.49% growth. This brings the company's revenue in the last twelve months to 5.23B, down -0.46% year-over-year. In the year 2025, Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd had annual revenue of 5.14B, down -1.70%.

• Revenue (ttm): 5.23B
• Revenue Growth: -0.46%
• P/S Ratio: 0.48
• Revenue / Employee: 1.07M
• Employees: 4,887
• Market Cap: 2.49B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.14B	-89.18M	-1.70%
Dec 31, 2024	5.23B	1.33B	34.07%
Dec 31, 2023	3.90B	611.18M	18.56%
Jan 1, 2023	3.29B	700.15M	27.01%
Dec 31, 2021	2.59B	252.41M	10.79%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 4, 2026

Data Sources Report a data error